NTRPNextTrip Inc.


$ 2.70 $ -0.05 (-1.9 %)    

Thursday, 16-May-2024 15:47:22 EDT
QQQ $ 454.82 $ 3.15 (0.7 %)
DIA $ 398.57 $ -1.85 (-0.46 %)
SPY $ 530.36 $ 0.61 (0.12 %)
TLT $ 91.26 $ -0.27 (-0.3 %)
GLD $ 225.37 $ 0.90 (0.4 %)
$ 2.58
$ 2.70
$ 0.00 x 0
$ 0.00 x 0
$ 2.70 - $ 2.70
$ 2.06 - $ 9.40
5,760
na
na
$ 1.37
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 neurotrope-inc-board-approves-spin-off-of-neurotrope-bioscience-inc

Spin-Off Distribution is Conditional Upon the Closing of Neurotrope's Proposed Merger with Metuchen Pharmaceuticals NEW YO...

 insider-buys-neurotrope-stock
Insider Buys Neurotrope Stock
11/02/2020 15:00:15

  Neurotrope Inc (NASDAQ:NTRP) was trading 1.10% higher from the previous closing price. A Form 4 filing filed with the SEC on...

 insider-buys-neurotropes-stock
Insider Buys Neurotrope's Stock
10/26/2020 15:36:01

Neurotrope Inc (NASDAQ:NTRP) was trading 3.6% higher from the previous closing price. A Form 4 filing filed with the SEC on Mon...

 insider-buys-neurotrope-stock
Insider Buys Neurotrope Stock
10/22/2020 16:04:12

A Form 4 filing filed with the SEC on Thursday, October 22 showed that Schechter Jonathan bought 2,012 shares of Neurotrope Inc...

 insider-buys-neurotropes-stock
Insider Buys Neurotrope's Stock
10/20/2020 15:21:52

Neurotrope Inc (NASDAQ:NTRP) was trading 2.1% higher from the previous closing price. A Form 4 filing filed with the SEC on Tue...

 insider-buys-neurotropes-shares
Insider Buys Neurotrope's Shares
10/19/2020 15:43:57

Neurotrope Inc (NASDAQ:NTRP) was trading 4.6% higher from the previous closing price. Silverman Joshua filed a Form 4 with the ...

 neurotrope-reports-deal-with-worldwide-clinical-trials-to-conduct-ongoing-phase-2-study-of-bryostatin-1-for-alzheimers

Neurotrope, Inc. (NASDAQ:NTRP) ("Neurotrope" or the "Company") today announced that its wholly-owned subsidiary...

Core News & Articles

By Anita Dushyanth, PhD NASDAQ:INMB | NASDAQ:NTRP | TSX:PMN.TO Rethinking the approach to treat Alzheimer's disease

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION